Bioheart, Inc. To Introduce At-domestic Heart Failure Monitor For Congestive Heart Failure Patients
Bioheart, Inc. (Nasdaq: BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, announced it has secured worldwide non-exclusive distribution rights to the Bioheart 3370 Heart Failure Monitor, an interactive and simple-to-use at-home intelligent device designed specifically to improve available healthcare to patients external hospitals who are suffering from heart failure.
Original post by Women’s Health / Gynecology News From Medical News Today
Related Articles
Greater Disability chases Congestive Heart Failure, Increased Nursing domestic Admissions Final info From The Bioheart Seismic Trial propose Safety, Efficacy Of Autologous Stem-Cell Therapy For Treating Congestive Heart Failure Bioheart Announces 35 main U.S. Heart Failure Centers Engaged In Phase II/III Marvel Trial Of Myogenic Cells For Treating Advanced Heart Failure Findings On Congestive Heart Failure And Atrial Fibrillation Presented By The Montreal Heart Institute Using “Smart Scales” For Congestive Heart Failure Monitoring Could Save NHS by £60M A Year And Help Save Thousands Of Lives, UK
No comments yet. Be the first.
Leave a reply
